<SEC-DOCUMENT>0001171843-25-004062.txt : 20250624
<SEC-HEADER>0001171843-25-004062.hdr.sgml : 20250624
<ACCEPTANCE-DATETIME>20250624170126
ACCESSION NUMBER:		0001171843-25-004062
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250620
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250624
DATE AS OF CHANGE:		20250624

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anika Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				043145961
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		251069995

	BUSINESS ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730
		BUSINESS PHONE:		(781) 457-9000

	MAIL ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA THERAPEUTICS INC
		DATE OF NAME CHANGE:	19970114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k_062425.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ANIK="http://globenewswire.com/20250620">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_ANIK_globenewswire.com_20250620 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20250620_20250620 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000898437 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000004" name="dei:EntityCentralIndexKey">0000898437</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="anik-20250620.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000898437</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-20</xbrli:startDate>
        <xbrli:endDate>2025-06-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">UNITED STATES</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">SECURITIES AND EXCHANGE COMMISSION</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">Washington, D.C. 20549</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">FORM <span id="xdx_90B_edei--DocumentType_c20250620__20250620_zRM2SHhOHpJj"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">CURRENT REPORT</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PURSUANT TO SECTION 13 OR 15(d)</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">OF THE SECURITIES EXCHANGE ACT OF 1934</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">Date of Report (Date of earliest event reported): <span id="xdx_90D_edei--DocumentPeriodEndDate_c20250620__20250620_zMO76hLlnIwl"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 20, 2025</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><span id="xdx_90F_edei--EntityRegistrantName_c20250620__20250620_zdxqa0APwCmd"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000011" name="dei:EntityRegistrantName">Anika Therapeutics, Inc.</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i>(Exact name of registrant as specified in its charter)</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; width: 35%"><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20250620__20250620_z3wWt5sFNEs2"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td>
  <td style="text-align: center; width: 30%"><span id="xdx_900_edei--EntityFileNumber_c20250620__20250620_zqvbDabrvLRc"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000013" name="dei:EntityFileNumber">000-21326</ix:nonNumeric></span></td>
  <td style="text-align: center; width: 35%"><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20250620__20250620_zfY1pJIe5Ard"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000014" name="dei:EntityTaxIdentificationNumber">04-3145961</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center"><p style="margin-top: 0; margin-bottom: 0"><i>(State or other jurisdiction of</i></p>
                                 <p style="margin-top: 0; margin-bottom: 0"><i>incorporation or organization)</i></p></td>
  <td style="text-align: center"><i>Commission file number</i></td>
  <td style="text-align: center"><p style="margin-top: 0; margin-bottom: 0"><i>(I.R.S. Employer</i></p>
                                 <p style="margin-top: 0; margin-bottom: 0"><i>Identification No.)</i></p></td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20250620__20250620_zA5uP0SuyfB8"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000015" name="dei:EntityAddressAddressLine1">32 Wiggins Avenue</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressCityOrTown_c20250620__20250620_zsBJZXvROukh"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000016" name="dei:EntityAddressCityOrTown">Bedford</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20250620__20250620_zc8LsoJwvrQg"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000017" name="dei:EntityAddressStateOrProvince">MA</ix:nonNumeric></span> <span id="xdx_902_edei--EntityAddressPostalZipCode_c20250620__20250620_zuvO6BNvhB2a"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000018" name="dei:EntityAddressPostalZipCode">01730</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i>(Address of principal executive offices) (Zip code)</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><span id="xdx_90F_edei--CityAreaCode_c20250620__20250620_zk5yelRmHW1f"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000019" name="dei:CityAreaCode">(781)</ix:nonNumeric></span>-<span id="xdx_905_edei--LocalPhoneNumber_c20250620__20250620_zHjo05MxQA35"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000020" name="dei:LocalPhoneNumber">457-9000</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i>Registrant&#8217;s telephone number, including area code: </i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i>&#160;</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i></i></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i></i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_904_edei--WrittenCommunications_c20250620__20250620_zwdjPf4JWiY1"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span> <span style="font-size: 10pt">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</span></p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 4.5pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_905_edei--SolicitingMaterial_c20250620__20250620_zjtRFOFhD296"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span> <span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_900_edei--PreCommencementTenderOffer_c20250620__20250620_zRi0ac6o2NA9"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span> <span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20250620__20250620_zABLpiLNKwse"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span> <span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 44%; text-align: center"><b>Title of each class</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 18%; text-align: center"><b>Trading Symbol(s)</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 36%; text-align: center"><b>Name of each exchange on which registered</b></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span id="xdx_90B_edei--Security12bTitle_c20250620__20250620_zyreX0HcRXBh"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_90C_edei--TradingSymbol_c20250620__20250620_zd5nuffCfAck"><ix:nonNumeric contextRef="AsOf2025-06-20" id="Fact000027" name="dei:TradingSymbol">ANIK</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_903_edei--SecurityExchangeName_c20250620__20250620_ziWT1TWQ0Eul"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule
405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span style="font-size: 10pt">Emerging growth company </span><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20250620__20250620_znNZI5SIoQwb"><ix:nonNumeric contextRef="AsOf2025-06-20" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span style="font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. </span>&#9744;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 5.02.</b></td><td><b>Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><i>Amendment of the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan</i></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">On April 21, 2025, the board of directors, or the Board, of Anika Therapeutics, Inc., or the
Company, adopted and approved, subject to stockholder approval, an amendment, or the Amendment, to the Anika Therapeutics, Inc. 2017 Omnibus
Incentive Plan as previously amended, or the 2017 Plan. Stockholders approved the Amendment at the Company&#8217;s Annual Meeting of Stockholders
held on June 20, 2025, or the Annual Meeting, as described under Item 5.07 below. The Amendment increases the number of shares of common
stock reserved under the 2017 Plan by 475,000 from 5,285,000 to 5,760,000. Additionally, the Amendment provides that all 5,760,000 shares
authorized under the 2017 Plan may be granted as incentive stock options in accordance with Section 422 of the Internal Revenue Code of
1986. No other provisions of the 2017 Plan were amended by the Amendment.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">A summary of the principal features of the 2017 Plan is included in the proxy statement for
the Annual Meeting, which the Company filed with the Securities and Exchange Commission on April 28, 2025, and which the Company refers
to below as the Proxy Statement. The foregoing description is qualified in its entirety by reference to the text of the 2017 Plan, as
amended by the Amendment, which is filed as an exhibit to this Form 8-K and incorporated herein by reference.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 5.07.</b></td><td><b>Submission of Matters to a Vote of Security Holders.</b></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">The Company held the Annual Meeting on June 20, 2025. The Board solicited proxies for the Annual
Meeting pursuant to the Proxy Statement. There was no solicitation in opposition to the Board&#8217;s solicitation. The number of shares
of the Company&#8217;s common stock, $0.01 par value per share, entitled to vote at the Annual Meeting was 14,341,423. A total of 12,351,806
shares of common stock were present in person or by proxy at the Annual Meeting, representing 86.13% of the voting power entitled to vote
at the Annual Meeting. Each share of common stock was entitled to one vote with respect to each matter submitted to a vote at the Annual
Meeting, and the voting results reported below are final.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">The matters considered and voted on by the stockholders at the Annual Meeting and the votes
of the stockholders were as follows:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PROPOSAL 1</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Stockholders voted as follows with respect to election of each of the director nominees identified
in the Proxy Statement:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 31%"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Nominee</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 16%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>For</b></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Against</b></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Abstain</b></span></td>
    <td style="width: 3%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Broker Non-Votes</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="letter-spacing: -0.05pt">Cheryl R. Blanchard, Ph.D.</span></td>
    <td>&#160;</td>
    <td style="text-align: center">8,754,717</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">2,139,215</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.3pt">51,074</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.3pt">1,406,800</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="letter-spacing: -0.05pt">Joseph H. Capper</span></td>
    <td>&#160;</td>
    <td style="text-align: center">10,521,730</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">387,385</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.3pt">35,891</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.3pt">1,406,800</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="letter-spacing: -0.05pt">Glenn R. Larsen, Ph.D.</span></td>
    <td>&#160;</td>
    <td style="text-align: center">8,712,940</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">2,202,441</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.3pt">29,625</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.3pt">1,406,800</span></td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">As a result of this vote, Dr. Blanchard, Mr. Capper and Dr. Larsen were elected as Class II
directors to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until his
or her earlier resignation or removal.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PROPOSAL 2</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Stockholders ratified the appointment of Deloitte &amp; Touche LLP as the Company&#8217;s independent
registered public accounting firm for the fiscal year ending December 31, 2025. Stockholders voted as follows with respect to this ratification
proposal:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 25%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>For</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 24%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Against</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 24%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Abstain</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 24%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Broker Non-Votes</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">12,076,726</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">248,610</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">26,470</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">0</span></td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PROPOSAL 3</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Stockholders voted, on a non-binding, advisory basis, to approve the compensation paid to the
Company&#8217;s named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and
Analysis, compensation tables and narrative discussion set forth in the Proxy Statement. Stockholders voted as follows with respect to
this proposal:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 25%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>For</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 24%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Against</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 24%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Abstain</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 24%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Broker Non-Votes</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">8,374,076</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">2,529,081</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">41,849</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">1,406,800</span></td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PROPOSAL 4</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Stockholders approved the Amendment with respect to the 2017 Plan. Stockholders voted as follows
with respect to this proposal:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 25%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>For</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 24%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Against</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 24%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Abstain</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 24%; text-align: center"><span style="font-size: 10pt; letter-spacing: -0.1pt"><b>Broker Non-Votes</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">8,297,563</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">2,608,925</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">38,518</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="letter-spacing: -0.05pt">1,406,800</span></td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 56.15pt"><b>Item 9.01.</b></td><td><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1pt solid; width: 7%"><b>Exhibit No.</b></td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: center; width: 92%"><b>Description</b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><a href="exh_101.htm">10.1&#8224;</a></td>
  <td>&#160;</td>
  <td><a href="exh_101.htm">Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (as amended effective June 20, 2025) </a></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>104</td>
  <td>&#160;</td>
  <td>Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt"></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#8224; Management contract or compensatory
plan or arrangement.</span></p>


<p style="margin: 0pt 0; font-size: 10pt"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt; text-align: center"><b>SIGNATURE</b></p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2"><b>Anika Therapeutics, Inc.</b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td colspan="2">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%">Date: June 24, 2025</td>
  <td style="width: 5%">By:</td>
  <td style="width: 35%"> <span style="text-decoration: underline">/s/ <span style="font-variant: small-caps">Cheryl R. Blanchard</span></span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>Cheryl R. Blanchard</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>President and Chief Executive Officer</td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">4</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwkAMRU/QO4RZi50WddGdFhWxihQRt4NNZbCdlMyo7ZG8pdMWMQRC8v/LF2IitrTRFTJcV3kGZ6ybSjmEHEtkNDf0jnS3T8DPHO/aOlbGDesPTMkz6JnFVN78fXC+tMUiAbkI41kYzyGSyVzC8iCCXk/JlLpA47SqQJkCTkwNa3SKu/HDWbVkqO6GpAuy1WQSiKZylD8QyyiGI73Um/hhIctSEUyGCsSW6dl417p1aHoS1hXWPs6O9L+DL8G8Sks= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exh_101.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">ANIKA
THERAPEUTICS, INC.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">2017 OMNIBUS INCENTIVE PLAN</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">(As amended June 20,
2025)</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Anika Therapeutics, Inc. sets forth herein the terms
of its 2017 Omnibus Incentive Plan.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">PURPOSE</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Plan is intended to enhance the ability of the
Company and its Affiliates to attract and retain highly qualified officers, Non-employee Directors, employees, consultants and advisors,
and to motivate such individuals to serve the Company and its Affiliates and to expend maximum effort to improve the business results
and earnings of the Company, by providing to such persons an opportunity to acquire or increase a direct proprietary interest in the operations
and future success of the Company. To this end, the Plan provides for the grant of stock options, stock appreciation rights (&ldquo;<B>SARs</B>&rdquo;),
restricted stock, restricted stock units (&ldquo;<B>RSUs</B>&rdquo;), unrestricted stock, other share-based awards and cash awards. Any
of these awards may, but need not, be made as performance incentives to reward attainment of performance goals in accordance with the
terms hereof. Upon the Plan becoming effective, no further awards shall be made under the Prior Plan.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">DEFINITIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">For purposes of interpreting the Plan and related documents
(including Award Agreements), the following definitions shall apply:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Acquiror<FONT STYLE="font-weight: normal">&rdquo;
shall have the meaning set forth in </FONT>Section&nbsp;15.2.1<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Affiliate<FONT STYLE="font-weight: normal">&rdquo;
means any company or other trade or business that &ldquo;controls,&rdquo; is &ldquo;controlled by&rdquo; or is &ldquo;under common control
with&rdquo; the Company within the meaning of Rule 405 of Regulation C under the Securities Act, including any Subsidiary. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Annual
Incentive Award<FONT STYLE="font-weight: normal">&rdquo; means a cash-based Performance Award with a performance period that is the Company&rsquo;s
fiscal year or other 12-month (or shorter) performance period as specified under the terms of the Award as approved by the Board.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Award<FONT STYLE="font-weight: normal">&rdquo;
means a grant under the Plan of an Option, SAR, Restricted Stock, RSU, Other Share-based Award or cash award. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Award
Agreement<FONT STYLE="font-weight: normal">&rdquo; means a written agreement between the Company and a Participant, or notice from the
Company or an Affiliate to a Participant that evidences and sets out the terms of an Award. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Board</B>&rdquo; means the Board of Directors of the Company<B>.</B></P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Business
Combination<FONT STYLE="font-weight: normal">&rdquo; shall have the meaning set forth in </FONT>Section&nbsp;15.2.2<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Cause<FONT STYLE="font-weight: normal">&rdquo;
shall be defined as that term is defined in the Participant&rsquo;s offer letter or other applicable employment agreement; or, if there
is no such definition, &ldquo;Cause&rdquo; means, as determined by the Company in its sole discretion and unless otherwise provided in
the applicable Award Agreement: (i) any material breach by the Participant of any agreement between the Participant and the Company; (ii)
the conviction of or plea of nolo contendere by the Participant to a felony or a crime involving moral turpitude; or (iii) any material
misconduct or willful and deliberate non-performance (other than by reason of disability) by the Participant of the Participant&rsquo;s
duties to the Company. A Separation from Service for Cause shall be deemed to include a determination by the Company in its sole discretion
following a Participant&rsquo;s Separation from Service that circumstances existing prior to such Separation from Service would have entitled
the Company or an Affiliate to have terminated the Participant&rsquo;s service for Cause. All rights a Participant has or may have under
the Plan shall be suspended automatically during the pendency of any investigation by the Company, or during any negotiations between
the Company and the Participant, regarding any actual or alleged act or omission by the Participant of the type described in the applicable
definition of Cause.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Change in Control</B>&rdquo; shall have the meaning set forth
in <B>Section&nbsp;15.2.2</B>.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Code</B>&rdquo; means the Internal Revenue Code of 1986.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Committee</B>&rdquo; means the Compensation Committee of the Board,
or such other committee as determined by the Board. The Compensation Committee of the Board may designate a subcommittee of its members
to serve as the Committee (to the extent the Board has not designated another person, committee or entity as the Committee). The Board
will cause the Committee to satisfy the applicable requirements of any securities exchange on which the Common Stock may then be listed.
For purposes of Awards to Covered Employees intended to qualify as Performance-Based Compensation, to the extent required by Section&nbsp;162(m),
Committee means all of the members of the Compensation Committee who are &ldquo;outside directors&rdquo; within the meaning of Section&nbsp;162(m).
For purposes of Awards to Participants who are subject to Section&nbsp;16 of the Exchange Act, Committee means all of the members of the
Compensation Committee who are &ldquo;non-employee directors&rdquo; within the meaning of Rule 16b-3 adopted under the Exchange Act.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Company</B>&rdquo; means Anika Therapeutics, Inc., a Massachusetts
corporation, or any successor corporation.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Common Stock</B>&rdquo; means the common stock of the Company.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Consultant<FONT STYLE="font-weight: normal">&rdquo;
means a consultant or advisor that provides bona fide services to the Company or any Affiliate and who qualifies as a consultant or advisor
under Form S-8.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Covered
Employee<FONT STYLE="font-weight: normal">&rdquo; means a Participant who is a &ldquo;covered employee&rdquo; within the meaning of Section&nbsp;162(m)
as qualified by </FONT>Section&nbsp;12.4<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Disability<FONT STYLE="font-weight: normal">&rdquo;
shall be defined as that term is defined in the Participant&rsquo;s offer letter or other applicable employment agreement; or, if there
is no such definition, &ldquo;Disability&rdquo; means, as determined by the Company in its sole discretion and unless otherwise provided
in the applicable Award Agreement, the Participant is unable to perform each of the essential duties of such Participant&rsquo;s position
by reason of a medically determinable physical or mental impairment which is potentially permanent in character or which can be expected
to last for a continuous period of not less than 12 months; <I>provided</I>, <I>however</I>, that, with respect to rules regarding expiration
of an Incentive Stock Option following termination of the Participant&rsquo;s employment, &ldquo;Disability&rdquo; means &ldquo;permanent
and total disability&rdquo; as set forth in Code Section&nbsp;22(e)(3).</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Effective
Date<FONT STYLE="font-weight: normal">&rdquo; means June 13, 2017, the date the Plan was approved by the Stockholders. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Exchange
Act<FONT STYLE="font-weight: normal">&rdquo; means the Securities Exchange Act of 1934.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Fair
Market Value<FONT STYLE="font-weight: normal">&rdquo; means, as of any date, the value of the Common Stock as determined below. If the
Common Stock is listed on any established stock exchange or a national market system, including without limitation, the New York Stock
Exchange or the NASDAQ Stock Market, the Fair Market Value shall be the closing price of a share of Common Stock (or if no sales were
reported the closing price on the date immediately preceding such date) as quoted on such exchange or system on the day of determination.
In the absence of an established market for the Common Stock, the Fair Market Value shall be determined in good faith by the Board and
such determination shall be conclusive and binding on all persons. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Family
Member<FONT STYLE="font-weight: normal">&rdquo; means a person who is a spouse, former spouse, child, stepchild, grandchild, parent, stepparent,
grandparent, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother, sister, brother-in-law or sister-in-law,
including adoptive relationships, of the applicable individual, any person sharing the applicable individual&rsquo;s household (other
than a tenant or employee), a trust in which any one or more of these persons have more than 50% of the beneficial interest, a foundation
in which any one or more of these persons (or the applicable individual) control the management of assets, and any other entity in which
one or more of these persons (or the applicable individual) own more than 50% of the voting interests.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Grant
Date<FONT STYLE="font-weight: normal">&rdquo; means the latest to occur of (i)&nbsp;the date as of which the Board approves an Award,
(ii)&nbsp;the date on which the recipient of an Award first becomes eligible to receive an Award under </FONT>Section&nbsp;6 <FONT STYLE="font-weight: normal">or
(iii)&nbsp;such other date as may be specified by the Board in the Award Agreement. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Incentive
Stock Option<FONT STYLE="font-weight: normal">&rdquo; means an &ldquo;incentive stock option&rdquo; within the meaning of Code Section&nbsp;422.
</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Incumbent
Directors<FONT STYLE="font-weight: normal">&rdquo;shall have the meaning set forth in </FONT>Section&nbsp;15.2.2<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>New
Shares<FONT STYLE="font-weight: normal">&rdquo; shall have the meaning set forth in </FONT>Section&nbsp;15.1<FONT STYLE="font-weight: normal">.
</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Non-employee
Director<FONT STYLE="font-weight: normal">&rdquo; means a member of the Board or the board of directors of an Affiliate, in each case
who is not an officer or employee of the Company or any Affiliate. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Nonqualified
Stock Option<FONT STYLE="font-weight: normal">&rdquo; means an Option that is not an Incentive Stock Option. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Option<FONT STYLE="font-weight: normal">&rdquo;
means an option to purchase one or more Shares pursuant to the Plan. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Option
Price<FONT STYLE="font-weight: normal">&rdquo; means the exercise price for each Share subject to an Option. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Other
Share-based Awards<FONT STYLE="font-weight: normal">&rdquo; means Awards consisting of Share units, or other Awards, valued in whole or
in part by reference to, or otherwise based on, Shares.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Participant<FONT STYLE="font-weight: normal">&rdquo;
shall mean a person who, as a Service Provider, has been granted an Award under the Plan; <I>provided</I>, <I>however</I>, that in the
case of the death or Disability of a Participant, the term &ldquo;Participant&rdquo; refers to the Participant&rsquo;s estate or other
legal representative acting in a fiduciary capacity on behalf of the Participant under applicable state law and court supervision. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Performance
Award<FONT STYLE="font-weight: normal">&rdquo; means an Award made subject to the attainment of performance goals (as described in </FONT>Section&nbsp;12<FONT STYLE="font-weight: normal">)
over a performance period established by the Committee, and includes an Annual Incentive Award.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Performance-Based
Compensation<FONT STYLE="font-weight: normal">&rdquo; means &ldquo;performance-based compensation&rdquo; under Section&nbsp;162(m).</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Plan<FONT STYLE="font-weight: normal">&rdquo;
means this Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Policy<FONT STYLE="font-weight: normal">&rdquo;
shall have the meaning set forth in </FONT>Section&nbsp;3.2.2<FONT STYLE="font-weight: normal">. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Prior
Plan<FONT STYLE="font-weight: normal">&rdquo; means the Anika Therapeutics, Inc. Second Amended and Restated 2003 Stock Option and Incentive
Plan, as amended. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Purchase
Price<FONT STYLE="font-weight: normal">&rdquo; means the purchase price for each Share pursuant to a grant of Restricted Stock. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Restricted
Stock<FONT STYLE="font-weight: normal">&rdquo; means restricted Shares, awarded to a Participant pursuant to </FONT>Section&nbsp;10<FONT STYLE="font-weight: normal">.
</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Restricted
Stock Unit<FONT STYLE="font-weight: normal">&rdquo; or &ldquo;</FONT>RSU<FONT STYLE="font-weight: normal">&rdquo; means a bookkeeping
entry representing the equivalent of Shares, awarded to a Participant pursuant to </FONT>Section&nbsp;10<FONT STYLE="font-weight: normal">.
</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>SAR
Exercise Price<FONT STYLE="font-weight: normal">&rdquo; means the per Share exercise price of a SAR granted to a Participant under </FONT>Section&nbsp;9<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>SEC<FONT STYLE="font-weight: normal">&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Section&nbsp;162(m)<FONT STYLE="font-weight: normal">&rdquo;
means Code Section&nbsp;162(m).</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Section&nbsp;409A<FONT STYLE="font-weight: normal">&rdquo;
means Code Section&nbsp;409A. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Securities
Act<FONT STYLE="font-weight: normal">&rdquo; means the Securities Act of 1933.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Separation
from Service<FONT STYLE="font-weight: normal">&rdquo; means the termination of the applicable Participant&rsquo;s employment with, and
performance of services for, the Company and each Affiliate. A Participant employed by, or performing services for, an Affiliate or a
division of the Company or an Affiliate shall not be deemed to incur a Separation from Service if such Affiliate or division ceases to
be an Affiliate or division of the Company, as the case may be, and the Participant immediately thereafter becomes an employee of (or
service provider to), or member of the board of directors of, the Company or an Affiliate or a successor company or an affiliate or subsidiary
thereof. Approved temporary absences from employment because of illness, vacation or leave of absence and transfers among the Company
and its Affiliates shall not be considered Separations from Service. Notwithstanding the foregoing, with respect to any Award that constitutes
nonqualified deferred compensation under Section&nbsp;409A, &ldquo;Separation from Service&rdquo; shall mean a &ldquo;separation from
service&rdquo; as defined under Section&nbsp;409A.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Service
Period<FONT STYLE="font-weight: normal">&rdquo; shall have the meaning set forth in </FONT>Section&nbsp;10.1<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Service
Provider<FONT STYLE="font-weight: normal">&rdquo; means an employee, officer, Non-employee Director or Consultant of the Company or an
Affiliate. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Share<FONT STYLE="font-weight: normal">&rdquo;
means a share of Common Stock.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Stock
Appreciation Right<FONT STYLE="font-weight: normal">&rdquo; or &ldquo;</FONT>SAR<FONT STYLE="font-weight: normal">&rdquo; means a right
granted to a Participant pursuant to </FONT>Section&nbsp;9<FONT STYLE="font-weight: normal">. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Stockholders<FONT STYLE="font-weight: normal">&rdquo;
means the stockholders of the Company.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subsidiary<FONT STYLE="font-weight: normal">&rdquo;
means any &ldquo;subsidiary corporation&rdquo; of the Company within the meaning of Code Section&nbsp;424(f). </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Substitute
Award<FONT STYLE="font-weight: normal">&rdquo; means any Award granted in assumption of or in substitution for an award of a company or
business acquired by the Company or an Affiliate or with which the Company or an Affiliate combines. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Ten
Percent Stockholder<FONT STYLE="font-weight: normal">&rdquo; means an individual who owns more than 10% of the total combined voting power
of all classes of outstanding stock of the Company, its parent or any of its Subsidiaries. In determining stock ownership, the attribution
rules of Code Section&nbsp;424(d) shall be applied. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Termination
Date<FONT STYLE="font-weight: normal">&rdquo; means the date that is 10 years after the Effective Date, unless the Plan is earlier terminated
by the Board under </FONT>Section&nbsp;5.2<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Voting
Securities<FONT STYLE="font-weight: normal">&rdquo; shall have the meaning set forth in </FONT>Section&nbsp;15.2.2<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">ADMINISTRATION OF THE PLAN</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
General</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board shall have such powers and authorities related
to the administration of the Plan as are consistent with the Company&rsquo;s certificate of incorporation and bylaws and applicable law.
The Board shall have the power and authority to delegate its responsibilities hereunder to the Committee, which shall have full authority
to act in accordance with its charter, and with respect to the power and authority of the Board to act hereunder, all references to the
Board shall be deemed to include a reference to the Committee, unless such power or authority is specifically reserved by the Board. Except
as specifically provided in <B>Section&nbsp;14</B> or as otherwise may be required by applicable law, regulatory requirement or the certificate
of incorporation or the bylaws of the Company, the Board shall have full power and authority to take all actions and to make all determinations
required or provided for under the Plan, any Award or any Award Agreement, and shall have full power and authority to take all such other
actions and make all such other determinations not inconsistent with the specific terms and provisions of the Plan that the Board deems
to be necessary or appropriate to the administration of the Plan. The Committee shall administer the Plan; <I>provided</I>, <I>however</I>,
the Board shall retain the right to exercise the authority of the Committee to the extent consistent with applicable law and the applicable
requirements of any securities exchange on which the Common Stock may then be listed. All actions, determinations and decisions by the
Board or the Committee under the Plan or any Award Agreement, or with respect to any Award, shall be in the sole discretion of the Board
and shall be final, binding and conclusive on all persons. Without limitation, the Board shall have full and final power and authority,
subject to the other terms of the Plan, to:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">designate Participants;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">determine the type or types of Awards to be made to Participants;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">determine the number of Shares to be subject to an Award;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">establish the terms of each Award (including the Option Price of any Option, the nature and duration of
any restriction or condition (or provision for lapse thereof) relating to the vesting, exercise, transfer or forfeiture of an Award or
the Shares subject thereto and any terms or conditions that may be necessary to qualify Options as Incentive Stock Options);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">subject to applicable law, delegate its authority and duties to the Chief Executive Officer with respect
to the granting of Options to individuals who are not Covered Employees or &ldquo;insiders&rdquo; within the meaning of Section 16 of
the Exchange Act. Any such delegation by the Board shall include a limitation as to the amount of Options that may be granted during the
period of the delegation and shall contain guidelines as to the determination of the exercise price and the vesting criteria. The Board
may revoke or amend the terms of a delegation at any time but such action shall not invalidate any prior actions of the Board&rsquo; delegate
or delegates that were consistent with the terms of the Plan.;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">prescribe the form of each Award Agreement; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD></TD><TD>(vii)</TD><TD COLSPAN="2" STYLE="text-align: justify">amend, modify or supplement the terms of any outstanding Award including the authority, in order to effectuate
the purposes of the Plan, to modify Awards to foreign nationals or individuals who are employed outside the United&nbsp;States to recognize
differences in local law, tax policy or custom.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
                                                         <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD><B>3.2.</B></TD><TD COLSPAN="2" STYLE="text-align: justify"><B>Separation from Service for Cause; Clawbacks</B></TD></TR>
                                                         <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                              <TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                         <TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in"><B>3.2.1.</B></TD>
                              <TD STYLE="text-align: justify"><B>Separation from Service for Cause</B></TD></TR>
                                                         </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Company may annul an Award if the Participant incurs
a Separation from Service for Cause.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in"><B>3.2.2.</B></TD>
                              <TD STYLE="text-align: justify"><B>Clawbacks</B></TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">All awards, amounts or benefits received or outstanding
under the Plan shall be subject to clawback, cancellation, recoupment, rescission, payback, reduction or other similar action in accordance
with the terms of any Company clawback or similar policy (the &ldquo;<B>Policy</B>&rdquo;) or any applicable law related to such actions,
as may be in effect from time to time. A Participant&rsquo;s acceptance of an Award shall be deemed to constitute the Participant&rsquo;s
acknowledgement of and consent to the Company&rsquo;s application, implementation and enforcement of any applicable Policy that may apply
to the Participant, whether adopted prior to or following the Effective Date, and any provision of applicable law relating to clawback,
cancellation, recoupment, rescission, payback or reduction of compensation, and the Participant&rsquo;s agreement that the Company may
take such actions as may be necessary to effectuate any such policy or applicable law, without further consideration or action.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>3.3.</B></TD><TD STYLE="text-align: justify"><B>Deferral Arrangement</B></TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board may permit or require the deferral of any
Award payment into a deferred compensation arrangement, subject to such rules and procedures as it may establish and in accordance with
Section&nbsp;409A, which may include provisions for the payment or crediting of interest or dividend equivalents as provided in <B>Section
17.10</B>, including converting such credits into deferred Share units.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>3.4.</B></TD><TD STYLE="text-align: justify"><B>No Liability</B></TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">No member of the Board or of the Committee shall be
liable for any action or determination made in good faith with respect to the Plan, any Award or Award Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>3.5.</B></TD><TD STYLE="text-align: justify"><B>Book Entry</B></TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding any other provision of the Plan to
the contrary, the Company may elect to satisfy any requirement under the Plan for the delivery of stock certificates through the use of
book entry.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>3.6.</B></TD><TD STYLE="text-align: justify"><B>No Repricing</B></TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding any provision herein to the contrary,
the repricing or substitution of Options or SARs is prohibited without prior approval of the Stockholders. For this purpose, a &ldquo;repricing&rdquo;
means any of the following (or any other action that has the same effect as any of the following): (i) changing the terms or conditions
of an Option or SAR to lower its Option Price or SAR Exercise Price; (ii) any other action that is treated as a &ldquo;repricing&rdquo;
under generally accepted accounting principles; and (iii) repurchasing for cash or canceling an Option or SAR at a time when its Option
Price or SAR Exercise Price is greater than the Fair Market Value of the underlying Shares in exchange for or substitution of another
Award, unless the cancellation and exchange occurs in connection with a change in capitalization or similar change under <B>Section&nbsp;15</B>.
A cancellation and exchange under clause (iii) would be considered a &ldquo;repricing&rdquo; regardless of whether it is treated as a
&ldquo;repricing&rdquo; under generally accepted accounting principles and regardless of whether it is voluntary on the part of the Participant.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD>4.</TD><TD COLSPAN="2" STYLE="text-align: justify">STOCK SUBJECT TO THE PLAN</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                             <TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">4.1.</TD>
               <TD STYLE="text-align: justify">Authorized
Number of Shares</TD></TR>
                                                                                                                             </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to adjustment under <B>Section&nbsp;15</B>,
the total number of Shares authorized to be awarded under the Plan shall not exceed 5,760,000 shares. The grant of any full value Award
(i.e., an Award other than an Option or a SAR) shall be deemed, for purposes of determining the number of Shares available for issuance
under this <B>Section 4.1</B>, as an Award of two (2) Shares for each Share actually subject to the Award. The grant of an Option or SAR
shall be deemed, for purposes of determining the number of Shares available for issuance under this <B>Section 4.1</B>, as an Award for
one (1) Share for each such Share actually subject to the Award. Any Shares returned to the Plan pursuant to <B>Section 4.2</B> shall
be returned to the reserved pool of Shares under the Plan in the same manner. In addition, Shares underlying any outstanding award granted
under a Prior Plan that, following the Effective Date, expires, or is terminated, surrendered or forfeited for any reason without issuance
of Shares shall be available for the grant of new Awards. As provided in <B>Section&nbsp;1</B>, no new awards shall be granted under the
Prior Plan following the Effective Date. Shares issued under the Plan may consist in whole or in part of authorized but unissued Shares,
treasury Shares or Shares purchased on the open market or otherwise.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">4.2.</TD>
               <TD STYLE="text-align: justify">Share Counting</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">4.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-weight: normal">Any Award settled in cash shall not be counted as issued Shares for any purpose under the Plan.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">4.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-weight: normal">If any Award expires, or is terminated, surrendered or forfeited, in whole or in part, the unissued
Shares covered by such Award shall again be available for the grant of Awards.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">4.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-weight: normal">If Shares issued pursuant to the Plan are repurchased by, or are surrendered or forfeited to the Company
at no more than cost, such Shares shall again be available for the grant of Awards.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">4.2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">If Shares issuable upon exercise, vesting or settlement of an Award, or Shares owned by a Participant
(which are not subject to any pledge or other security interest) are surrendered or tendered to the Company in payment of the Option Price
or Purchase Price of an Award, withheld upon the net settlement or net exercise of Options or stock-settled SARs granted under the Plan,
or any taxes required to be withheld in respect of an Award, in each case, in accordance with the terms of the Plan and any applicable
Award Agreement, such surrendered or tendered Shares shall not be available again for the grant of Awards.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">4.2.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-weight: normal">Substitute Awards shall not be counted against the number of Shares available for the grant of Awards.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: justify">4.3.</TD>
               <TD COLSPAN="2" STYLE="text-align: justify">Award Limits</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
               <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
               <TD STYLE="text-align: justify; width: 0.5in">4.3.1.</TD>
               <TD STYLE="text-align: justify">Incentive Stock Options</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Subject to adjustment under <B>Section&nbsp;15</B>, 5,760,000
Shares available for issuance under the Plan shall be available for issuance as Incentive Stock Options.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
               <TD STYLE="text-align: justify; width: 0.5in">4.3.2.</TD>
               <TD STYLE="text-align: justify">Individual Award Limits for Section 162(m) -- Share-Based Awards</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Subject to adjustment under <B>Section 15</B>, the maximum
number of each type of Award (other than cash-based Performance Awards) granted to any Participant in any calendar year shall not exceed
the following number of Shares: (i) Options and SARs: 400,000 Shares; and (ii) all share-based Performance Awards (including Restricted
Stock, RSUs and Other Share-based Awards that are Performance Awards): 400,000 Shares.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
               <TD STYLE="text-align: justify; width: 0.5in">4.3.3.</TD>
               <TD STYLE="text-align: justify">Individual Award Limits for Section 162(m) -- Cash-Based Awards</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The maximum amount of cash-based Performance Awards intended
to qualify as Performance-Based Compensation granted to any Participant in any calendar year shall not exceed the following: (i) Annual
Incentive Awards: $1,000,000; and (ii) all other cash-based Performance Awards: $1,000,000.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
               <TD STYLE="text-align: justify; width: 0.5in">4.3.4.</TD>
               <TD STYLE="text-align: justify">Director Awards</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The maximum value of Awards granted during any calendar
year to any Non-employee Director, taken together with any cash fees paid to such Non-employee Director during the calendar year and the
value of awards granted to the Non-employee Director under any other equity compensation plan of the Company or an Affiliate during the
calendar year, shall not exceed the following in total value (calculating the value of any Awards or other equity compensation plan awards
based on the fair market value as of grant date for financial reporting purposes): (i) $500,000 for the non-employee Chair or Lead Director
of the Board and (ii) $425,000 for each Non-employee Director other than the Chair or Lead Director of the Board; <I>provided, however</I>,
that awards granted to Non-employee Directors upon their initial election to the Board or the board of directors of an Affiliate shall
not be counted towards the limit under this <B>Section 4.3.4</B>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">EFFECTIVE DATE, DURATION AND AMENDMENTS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">5.1.</TD>
               <TD STYLE="text-align: justify">Term</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Plan shall be effective as of the Effective Date,
<I>provided</I> that it has been approved by the Stockholders. The Plan shall terminate automatically on the 10-year anniversary of the
Effective Date and may be terminated on any earlier date as provided in <B>Section&nbsp;5.2</B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">5.2.</TD>
               <TD STYLE="text-align: justify">Amendment and Termination of the Plan</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board may, at any time and from time to time, amend,
suspend or terminate the Plan as to any Awards which have not been made. An amendment shall be contingent on approval of the Stockholders
to the extent stated by the Board, required by applicable law or required by applicable securities exchange listing requirements. No Awards
shall be made after the Termination Date. The applicable terms of the Plan, and any terms applicable to Awards granted prior to the Termination
Date, shall survive the termination of the Plan and continue to apply to such Awards. No amendment, suspension or termination of the Plan
shall, without the consent of the Participant, materially impair rights or obligations under any Award theretofore awarded.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify">AWARD ELIGIBILITY AND LIMITATIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">6.1.</TD>
               <TD STYLE="text-align: justify">Service Providers</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to this <B>Section&nbsp;6</B>, Awards may be
made to any Service Provider as the Board may determine and designate from time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">6.2.</TD>
               <TD STYLE="text-align: justify">Successive Awards</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">An eligible person may receive more than one Award,
subject to such restrictions as are provided herein.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">6.3.</TD>
               <TD STYLE="text-align: justify">Stand-Alone, Additional, Tandem, and Substitute Awards</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to Section 3.6 above, Awards may be granted
either alone or in addition to, in tandem with, or in substitution or exchange for, any other Award or any award granted under another
plan of the Company, any Affiliate or any business entity to be acquired by the Company or an Affiliate, or any other right of a Participant
to receive payment from the Company or any Affiliate. Such additional, tandem or substitute or exchange Awards may be granted at any time.
If an Award is granted in substitution or exchange for another award, the Board shall have the right to require the surrender of such
other award in consideration for the grant of the new Award. Subject to the requirements of applicable law, the Board may make Awards
in substitution or exchange for any other award under another plan of the Company, any Affiliate or any business entity to be acquired
by the Company or an Affiliate. In addition, Awards may be granted in lieu of cash compensation, including in lieu of cash amounts payable
under other plans of the Company or any Affiliate, in which the value of Shares subject to the Award is equivalent in value to the cash
compensation (for example, RSUs or Restricted Stock).</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">6.4.</TD>
               <TD STYLE="text-align: justify">Minimum Vesting</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding any other provision of the Plan to
the contrary, Share-based Awards granted under the Plan shall vest no earlier than the first anniversary of the date the Award is granted,
excluding, for this purpose, any (i) Substitute Awards, (ii) Shares delivered in lieu of fully vested cash Awards, and (iii) Awards to
Non-employee Directors that vest on the earlier of the one year anniversary of the date of grant or the next annual meeting of stockholders
(provided that such vesting period under this clause (iii) may not be less than 50 weeks after grant; provided, that, the Board may grant
Share-based Awards without regard to the foregoing minimum vesting requirement with respect to a maximum of five percent (5%) of the available
share reserve authorized for issuance under the Plan pursuant to Section 4.1 (subject to adjustment under Section 15); and, provided further,
for the avoidance of doubt, that the foregoing restriction does not apply to the Committee&rsquo;s discretion to provide for accelerated
exercisability or vesting of any Award, including in cases of retirement, death, disability or a Change in Control, in the terms of the
Award or otherwise.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">AWARD AGREEMENT</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The grant of any Award may be contingent upon the Participant
executing an appropriate Award Agreement, in such form or forms as the Board shall from time to time determine. Without limiting the foregoing,
an Award Agreement may be provided in the form of a notice which provides that acceptance of the Award constitutes acceptance of all terms
of the Plan and the notice. Award Agreements granted from time to time or at the same time need not contain similar provisions but shall
be consistent with the terms of the Plan. Each Award Agreement evidencing an Award of Options shall specify whether such Options are intended
to be Nonqualified Stock Options or Incentive Stock Options, and in the absence of such specification such options shall be deemed Nonqualified
Stock Options.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify">TERMS AND CONDITIONS OF OPTIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">8.1.</TD>
               <TD STYLE="text-align: justify">Option Price</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Option Price of each Option shall be fixed by the
Board and stated in the related Award Agreement. The Option Price of each Option (except those that constitute Substitute Awards) shall
be at least the Fair Market Value on the Grant Date; <I>provided</I>, <I>however</I>, that in the event that a Participant is a Ten Percent
Stockholder as of the Grant Date, the Option Price of an Option granted to such Participant that is intended to be an Incentive Stock
Option shall be not less than 110 percent of the Fair Market Value on the Grant Date. In no case shall the Option Price of any Option
be less than the par value of a Share.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">8.2.</TD>
               <TD STYLE="text-align: justify">Vesting</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to <B>Section&nbsp;8.3</B>, each Option shall
become exercisable at such times and under such conditions (including performance requirements) as stated in the Award Agreement.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">8.3.</TD>
               <TD STYLE="text-align: justify">Term</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each Option shall terminate, and all rights to purchase
Shares thereunder shall cease, upon the expiration of the Option term stated in the Award Agreement not to exceed 10 years from the Grant
Date, or under such circumstances and on such date prior thereto as is set forth in the Plan or as may be fixed by the Board and stated
in the related Award Agreement; <I>provided</I>, <I>however</I>, that in the event that the Participant is a Ten Percent Stockholder,
an Option granted to such Participant that is intended to be an Incentive Stock Option at the Grant Date shall not be exercisable after
the expiration of five years from its Grant Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">8.4.</TD>
               <TD STYLE="text-align: justify">Limitations on Exercise of Option</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding any other provision of the Plan, in
no event may any Option be exercised, in whole or in part, (i)&nbsp;prior to the date the Plan is approved by the Stockholders as provided
herein or (ii)&nbsp;after the occurrence of an event which results in termination of the Option.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">8.5.</TD>
               <TD STYLE="text-align: justify">Method of Exercise</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">An Option that is exercisable may be exercised by the
Participant&rsquo;s delivery of a notice of exercise to the Company, setting forth the number of Shares with respect to which the Option
is to be exercised, accompanied by full payment for the Shares. To be effective, notice of exercise must be made in accordance with procedures
established by the Company from time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">8.6.</TD>
               <TD STYLE="text-align: justify">Rights of Holders of Options</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Unless otherwise provided in the applicable Award Agreement,
an individual holding or exercising an Option shall have none of the rights of a Stockholder (for example, the right to direct the voting
of the subject Shares) until the Shares covered thereby are fully paid and issued to him or her. An individual holding an Option shall
not have the right to receive cash or dividend payments or distributions attributable to the subject Shares until the Option has been
exercised and the Shares covered thereby are fully paid and issued to him or her. Except as provided in <B>Section&nbsp;15</B> or the
related Award Agreement, no adjustment shall be made for dividends, distributions or other rights for which the record date is prior to
the date of such issuance.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">8.7.</TD>
               <TD STYLE="text-align: justify">Delivery of Stock Certificates</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to <B>Section&nbsp;3.5</B>, promptly after
the exercise of an Option by a Participant and the payment in full of the Option Price, such Participant shall be entitled to the issuance
of a stock certificate which evidences, or electronic notice of a book entry which records, his or her ownership of the Shares subject
to the Option.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">8.8.</TD>
               <TD STYLE="text-align: justify">Limitations on Incentive Stock Options</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">An Option shall constitute an Incentive Stock Option
only (i)&nbsp;if the Participant of such Option is an employee of the Company or any Subsidiary of the Company; (ii)&nbsp;to the extent
specifically provided in the related Award Agreement; and (iii)&nbsp;to the extent that the aggregate Fair Market Value (determined at
the time the Option is granted) of the Shares with respect to which all Incentive Stock Options held by such Participant become exercisable
for the first time during any calendar year (under the Plan and all other plans of the Participant&rsquo;s employer and its Affiliates)
does not exceed $100,000. This limitation shall be applied by taking Options into account in the order in which they were granted. No
Option shall be treated as an Incentive Stock Option unless the Plan has been approved by the Stockholders in a manner intended to comply
with the stockholder approval requirements of Code Section 422(b)(1); <I>provided</I>, <I>however, </I>that any Option intended to be
an Incentive Stock Option shall not fail to be effective solely on account of a failure to obtain such approval, but rather such Option
shall be treated as a Nonqualified Stock Option unless and until such stockholder approval is obtained.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify">TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS (SAR<FONT STYLE="text-transform: none">s)</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">9.1.</TD>
               <TD STYLE="text-align: justify">Right to Payment</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">A SAR shall confer on the Participant a right to receive,
upon exercise thereof, the excess of (i)&nbsp;the Fair Market Value on the date of exercise over (ii)&nbsp;the SAR Exercise Price, as
determined by the Board. The Award Agreement for a SAR (except those that constitute Substitute Awards) shall specify the SAR Exercise
Price, which shall be fixed on the Grant Date as not less than the Fair Market Value on that date. SARs may be granted alone or in conjunction
with all or part of an Option or at any subsequent time during the term of such Option or in conjunction with all or part of any other
Award. A SAR granted in tandem with an outstanding Option following the Grant Date of such Option shall have a grant price that is equal
to the Option Price; <I>provided</I>, <I>however</I>, that the SAR&rsquo;s grant price may not be less than the Fair Market Value on the
Grant Date of the SAR to the extent required by Section&nbsp;409A.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">9.2.</TD>
               <TD STYLE="text-align: justify">Other Terms</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board shall determine at the Grant Date or thereafter,
the time or times at which and the circumstances under which a SAR may be exercised in whole or in part (including based on achievement
of performance goals or future service requirements), the time or times at which SARs shall cease to be or become exercisable following
Separation from Service or upon other conditions, the method of exercise, whether or not a SAR shall be in tandem or in combination with
any other Award and any other terms of any SAR.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">9.3.</TD>
               <TD STYLE="text-align: justify">Term of SARs</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The term of a SAR granted under the Plan shall be determined
by the Board; <I>provided</I>, <I>however</I>, that such term shall not exceed 10 years.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">9.4.</TD>
               <TD STYLE="text-align: justify">Payment of SAR Amount</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Upon exercise of a SAR, a Participant shall be entitled
to receive payment from the Company (in cash or Shares, as set forth in the Award Agreement) in an amount determined by multiplying:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the difference between the Fair Market Value on the date of exercise over the SAR Exercise Price; by</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the number of Shares with respect to which the SAR is exercised.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify">TERMS AND CONDITIONS OF RESTRICTED STOCK AND RESTRICTED STOCK UNITS (RSU<FONT STYLE="text-transform: none">s)</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">10.1.</TD>
               <TD STYLE="text-align: justify">
Restrictions (applicable to Restricted Stock and RSUs)</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">At the time of grant, the Board may establish a period
of time (a &ldquo;<B>Service Period</B>&rdquo;) and any additional restrictions including the satisfaction of corporate or individual
performance objectives applicable to an Award of Restricted Stock or RSUs. Each Award of Restricted Stock or RSUs may be subject to a
different Service Period and additional restrictions. Neither Restricted Stock nor RSUs may be sold, transferred, assigned, pledged or
otherwise encumbered or disposed of during the Service Period or prior to the satisfaction of any other applicable restrictions.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">10.2.</TD>
               <TD STYLE="text-align: justify">
Delivery of Shares (applicable to Restricted Stock and RSUs)</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to <B>Section&nbsp;3.5</B>, upon the expiration
or termination of any Service Period and the satisfaction of any other conditions prescribed by the Board, the restrictions applicable
to Shares of Restricted Stock or RSUs settled in Shares shall lapse, and, unless otherwise provided in the applicable Award Agreement,
a stock certificate for such Shares shall be delivered, free of all such restrictions, to the Participant or the Participant&rsquo;s beneficiary
or estate, as the case may be.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">10.3.</TD>
               <TD STYLE="text-align: justify">
Rights of Holders of Restricted Stock (applicable to Restricted Stock, not RSUs)</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Unless otherwise provided in the applicable Award Agreement,
holders of Restricted Stock shall have rights as Stockholders, including voting and dividend rights; <I>provided</I>, <I>however</I>,
any dividends with respect to the Restricted Stock shall be withheld by the Company for the Participant&rsquo;s account, and interest
may be credited on the amount of the dividends withheld at a rate and subject to such terms as determined by the Committee. The dividends
so withheld by the Committee and attributable to any particular share of Restricted Stock (and earnings thereon, if applicable) shall
be distributed to the Participant in cash or, at the discretion of the Committee, in Shares having a Fair Market Value equal to the amount
of such dividends, if applicable, upon the release of restrictions on such Share and, if such Share is forfeited, the Participant shall
have no right to such dividends.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">10.4.</TD>
               <TD STYLE="text-align: justify">
Purchase of Restricted Stock (applicable to Restricted Stock, not RSUs)</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Participant shall be required, to the extent required
by applicable law, to purchase the Restricted Stock from the Company at a Purchase Price equal to the greater of (i)&nbsp;the aggregate
par value of the Shares represented by such Restricted Stock or (ii)&nbsp;the Purchase Price, if any, specified in the related Award Agreement.
If specified in the Award Agreement, the Purchase Price may be deemed paid by services already rendered. The Purchase Price shall be payable
in a form described in <B>Section&nbsp;11</B> or, if so determined by the Board, in consideration for past services rendered.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">10.5.</TD>
               <TD STYLE="text-align: justify">
Restricted Stock Certificates (applicable to Restricted Stock, not RSUs)</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to <B>Section&nbsp;3.5</B>, the Company shall
issue, in the name of each Participant to whom Restricted Stock has been granted, stock certificates or other evidence of ownership representing
the total number of Shares of Restricted Stock granted to the Participant, as soon as reasonably practicable after the Grant Date. The
Board may provide in an Award Agreement that either (i)&nbsp;the Secretary of the Company shall hold any stock certificates for the Participant&rsquo;s
benefit until such time as the Restricted Stock is forfeited to the Company or the restrictions lapse or (ii)&nbsp;such certificates shall
be delivered to the Participant; <I>provided</I>, <I>however</I>, that such certificates shall bear a legend or legends that comply with
the applicable securities laws and regulations and make appropriate reference to the restrictions imposed under the Plan and the Award
Agreement.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">10.6.</TD>
               <TD STYLE="text-align: justify">
Rights of Holders of RSUs (applicable to RSUs, not Restricted Stock)</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
               <TD STYLE="text-align: justify; width: 0.5in">10.6.1.</TD>
               <TD STYLE="text-align: justify">Settlement of RSUs</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">RSUs may be settled in cash or Shares, as set forth in
the Award Agreement. The Award Agreement shall also set forth whether the RSUs shall be settled (i)&nbsp;within the time period specified
in Section 409A for short term deferrals or (ii)&nbsp;otherwise within the requirements of Section&nbsp;409A, in which case the Award
Agreement shall specify upon which events such RSUs shall be settled.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
               <TD STYLE="text-align: justify; width: 0.5in">10.6.2.</TD>
               <TD STYLE="text-align: justify">Voting and Dividend Rights</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Unless otherwise provided in the applicable Award Agreement,
holders of RSUs shall not have rights as Stockholders, including voting or dividend or dividend equivalents rights. Dividend equivalent
rights may be granted with respect to RSUs pursuant to <B>Section 17.10</B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
               <TD STYLE="text-align: justify; width: 0.5in">10.6.3.</TD>
               <TD STYLE="text-align: justify">Creditor&rsquo;s Rights</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">A holder of RSUs shall have no rights other than those
of a general creditor of the Company. RSUs represent an unfunded and unsecured obligation of the Company, subject to the terms of the
applicable Award Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD>11.</TD><TD COLSPAN="2" STYLE="text-align: justify">FORM OF PAYMENT FOR OPTIONS AND RESTRICTED STOCK</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                     <TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">11.1.</TD>
               <TD STYLE="text-align: justify">General Rule</TD></TR>
                                                                                                                                                     </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Payment of the Option Price for the Shares purchased
pursuant to the exercise of an Option or the Purchase Price for Restricted Stock shall be made in cash or in cash equivalents acceptable
to the Company, except as provided in this <B>Section&nbsp;11</B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">11.2.</TD>
               <TD STYLE="text-align: justify">Surrender of Shares</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">To the extent the Award Agreement so provides, payment
of the Option Price for Shares purchased pursuant to the exercise of an Option or the Purchase Price for Restricted Stock may be made
all or in part through the tender to the Company of Shares, which Shares shall be valued, for purposes of determining the extent to which
the Option Price or Purchase Price for Restricted Stock has been paid thereby, at their Fair Market Value on the date of exercise or surrender.
Notwithstanding the foregoing, in the case of an Incentive Stock Option, the right to make payment in the form of already-owned Shares
may be authorized only at the time of grant.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: justify; width: 0.5in">11.3.</TD>
               <TD STYLE="text-align: justify">
Cashless Exercise</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">With respect to an Option only (and not with respect
to Restricted Stock), to the extent permitted by law and to the extent the Award Agreement so provides, payment of the Option Price may
be made all or in part by delivery (on a form acceptable to the Company) of an irrevocable direction to a licensed securities broker acceptable
to the Company to sell Shares and to deliver all or part of the sales proceeds to the Company in payment of the Option Price and any withholding
taxes described in <B>Section&nbsp;17.3</B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">11.4.</TD>
    <TD STYLE="text-align: justify">Other Forms of Payment</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">To the extent the Award Agreement so provides, payment
of the Option Price or the Purchase Price for Restricted Stock may be made in any other form that is consistent with applicable laws,
regulations and rules, including the Company&rsquo;s withholding of Shares otherwise due to the exercising Participant.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify">TERMS AND CONDITIONS OF PERFORMANCE AWARDS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">12.1.</TD>
    <TD STYLE="text-align: justify">Performance Conditions</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The right of a Participant to exercise or receive a
grant or settlement of any Award, and the timing thereof, may be subject to such performance conditions as may be specified by the Board.
The Board may use such business criteria and other measures of performance as it may deem appropriate in establishing any performance
conditions, and may reduce the amounts payable under any Award subject to performance conditions, except as limited under <B>Section 12.2
</B>in the case of Performance-Based Compensation.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">12.2.</TD>
    <TD STYLE="text-align: justify">Performance Awards Granted to Designated Covered Employees</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If and to the extent that the Board determines that
a Performance Award to be granted to a Participant who is designated by the Board as likely to be a Covered Employee should qualify as
Performance-Based Compensation, the grant, exercise or settlement of such Performance Award shall be contingent upon achievement of pre-established
performance goals and other terms set forth in this <B>Section&nbsp;12.2</B>. Notwithstanding anything herein to the contrary, the Board
may provide for Performance Awards to Covered Employees that are not intended to qualify as Performance-Based Compensation.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">12.2.1.</TD>
    <TD STYLE="text-align: justify">Performance Goals Generally</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The performance goals for Performance Awards shall consist
of one or more business criteria and a targeted level or levels of performance with respect to each of such criteria, as specified by
the Board consistent with this <B>Section&nbsp;12.2</B>. Performance goals shall be objective and shall otherwise meet the requirements
of Section&nbsp;162(m), including the requirement that the level or levels of performance targeted by the Board result in the achievement
of performance goals being &ldquo;substantially uncertain.&rdquo; The Board may determine that Performance Awards shall be granted, exercised
or settled upon achievement of any one performance goal or that two or more of the performance goals must be achieved as a condition to
grant, exercise or settlement of the Performance Awards. Performance goals may be established on a Company-wide basis, or with respect
to one or more business units, divisions, Affiliates or business segments, as applicable. To the extent consistent with the requirements
of Section&nbsp;162(m), the Committee may determine at the time that goals under this <B>Section&nbsp;12 </B>are established the extent
to which measurement of performance goals may exclude the impact of charges for restructuring, discontinued operations, extraordinary
items, debt redemption or retirement, asset write downs, litigation or claim judgments or settlements, acquisitions or divestitures, foreign
exchange gains and losses and other extraordinary, unusual or non-recurring items, and the cumulative effects of tax or accounting changes
(each as defined by generally accepted accounting principles and as identified in the Company&rsquo;s financial statements or other SEC
filings). Performance goals may differ for Performance Awards granted to any one Participant or to different Participants.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">12.2.2.</TD>
    <TD STYLE="text-align: justify">Business Criteria</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">One or more of the following business criteria for the
Company, on a consolidated basis, or specified Affiliates or business units of the Company (except with respect to the total stockholder
return and earnings per share criteria), shall be used exclusively by the Board in establishing performance goals for Performance Awards:
(i) cash flow; (ii) earnings per share, as adjusted for any stock split, stock dividend or other recapitalization; (iii) earnings measures;
(iv) return on equity; (v) total stockholder return; (vi) share price performance, as adjusted for any stock split, stock dividend or
other recapitalization; (vii) return on capital; (viii) revenue; (ix) income; (x) profit margin; (xi) return on operating revenue; (xii)
brand recognition or acceptance; (xiii) customer satisfaction; (xiv) productivity; (xv) expense targets; (xvi) market share; (xvii) cost
control measures; (xviii) balance sheet metrics; (xix) strategic initiatives; (xx) implementation, completion or attainment of measurable
objectives with respect to recruitment or retention of personnel or employee satisfaction; (xxi) regulatory body approval for commercialization
of a product; (xxii) implementation or completion of critical projects; or (xxiii) any other business criteria established by the Board;
<I>provided</I>, <I>however</I>, that such business criteria shall include any derivations of business criteria listed above (<I>e.g.</I>,
income shall include pre-tax income, net income and operating income).</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">12.2.3.</TD>
    <TD STYLE="text-align: justify">
Timing for Establishing Performance Goals</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Performance goals shall be established not later than
90 days after the beginning of any performance period applicable to Performance Awards, or at such other date as may be required or permitted
for Performance-Based Compensation.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">12.2.4.</TD>
    <TD STYLE="text-align: justify">
Settlement of Performance Awards; Other Terms</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Settlement of Performance Awards may be in cash, Shares,
other Awards or other property. The Board may reduce the amount of a settlement otherwise to be made in connection with such Performance
Awards.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">12.3.</TD>
    <TD STYLE="text-align: justify">Written Determinations</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">All determinations by the Board as to the establishment
of performance goals, the amount of any Performance Award pool or potential individual Performance Awards and the achievement of performance
goals relating to Performance Awards, shall be made in writing in the case of any Award intended to qualify as Performance-Based Compensation
to the extent required by Section&nbsp;162(m). To the extent permitted by Section&nbsp;162(m), the Board may delegate any responsibility
relating to Performance Awards.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">12.4.</TD>
    <TD STYLE="text-align: justify">Status of Section&nbsp;12.2 Awards under Section&nbsp;162(m)</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">It is the intent of the Company that Performance Awards
under <B>Section&nbsp;12.2</B> granted to persons who are designated by the Board as likely to be Covered Employees within the meaning
of Section&nbsp;162(m) shall, if so designated by the Board, qualify as Performance-Based Compensation. Accordingly, the terms of <B>Section&nbsp;12.2</B>,
including the definitions of Covered Employee and other terms used therein, shall be interpreted in a manner consistent with Section&nbsp;162(m).
The foregoing notwithstanding, because the Board cannot determine with certainty whether a given Participant will be a Covered Employee
with respect to a fiscal year that has not yet been completed, the term Covered Employee as used herein shall mean only a person designated
by the Board, at the time of grant of Performance Awards, as likely to be a Covered Employee with respect to that fiscal year. If any
provision of the Plan or any agreement relating to such Performance Awards does not comply or is inconsistent with the requirements of
Section&nbsp;162(m), such provision shall be construed or deemed amended to the extent necessary to conform to such requirements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify">other SHARE-based awards</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">13.1.</TD>
    <TD STYLE="text-align: justify">Grant of Other Share-based Awards</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Other Share-based Awards may be granted either alone
or in addition to or in conjunction with other Awards. Other Share-based Awards may be granted in lieu of other cash or other compensation
to which a Service Provider is entitled from the Company or may be used in the settlement of amounts payable in Shares under any other
compensation plan or arrangement of the Company, including any other Company incentive compensation plan. The Board shall have the authority
to determine the persons to whom and the time or times at which such Awards will be made, the number of Shares to be granted pursuant
to such Awards, and all other terms of such Awards. Unless the Board determines otherwise, any such Award shall be confirmed by an Award
Agreement, which shall contain such provisions as the Board determines to be necessary or appropriate to carry out the intent of the Plan
with respect to such Award.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">13.2.</TD>
    <TD STYLE="text-align: justify">Terms of Other Share-based Awards</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Any Common Stock subject to Awards made under this
<B>Section&nbsp;13</B> may not be sold, assigned, transferred, pledged or otherwise encumbered prior to the date on which the Shares are
issued, or, if later, the date on which any applicable restriction, performance or deferral period lapses.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify">REQUIREMENTS OF LAW</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">14.1.</TD>
    <TD STYLE="text-align: justify">General</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Company shall not be required to sell or issue
any Shares under any Award if the sale or issuance of such Shares would constitute a violation by the Participant, any other individual
exercising an Option or the Company of any provision of any law or regulation of any governmental authority, including any federal or
state securities laws or regulations. If at any time the Board determines that the listing, registration or qualification of any Shares
subject to an Award upon any securities exchange or under any governmental regulatory body is necessary or desirable as a condition of,
or in connection with, the issuance or purchase of Shares hereunder, no Shares may be issued or sold to the Participant or any other individual
exercising an Option pursuant to such Award unless such listing, registration, qualification, consent or approval shall have been effected
or obtained free of any conditions not acceptable to the Company, and any delay caused thereby shall in no way affect the date of termination
of the Award. Specifically, in connection with the Securities Act, upon the exercise of any Option or the delivery of any Shares underlying
an Award, unless a registration statement under such Act is in effect with respect to the Shares covered by such Award, the Company shall
not be required to sell or issue such Shares unless the Board has received evidence satisfactory to it that the Participant or any other
individual exercising an Option may acquire such Shares pursuant to an exemption from registration under the Securities Act. The Company
may, but shall in no event be obligated to, register any securities covered hereby pursuant to the Securities Act. The Company shall not
be obligated to take any affirmative action in order to cause the exercise of an Option or the issuance of Shares pursuant to the Plan
to comply with any law or regulation of any governmental authority. As to any jurisdiction that expressly imposes the requirement that
an Option shall not be exercisable until the Shares covered by such Option are registered or are exempt from registration, the exercise
of such Option (under circumstances in which the laws of such jurisdiction apply) shall be deemed conditioned upon the effectiveness of
such registration or the availability of such an exemption. The Committee may require the Participant to sign such additional documentation,
make such representations and furnish such information as it may consider appropriate in connection with the grant of Awards or issuance
or delivery of Shares in compliance with applicable laws, rules and regulations.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 1pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">14.2.</TD>
    <TD STYLE="text-align: justify">
Rule 16b-3</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 1pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">During any time when the Company has a class of equity
security registered under Section&nbsp;12 of the Exchange Act, it is the intent of the Company that Awards and the exercise of Options
will qualify for the exemption provided by Rule 16b-3 under the Exchange Act. To the extent that any provision of the Plan or action by
the Board or Committee does not comply with the requirements of Rule 16b-3, it shall be deemed inoperative to the extent permitted by
law and deemed advisable by the Board, and shall not affect the validity of the Plan. In the event that Rule 16b-3 is revised or replaced,
the Board may modify the Plan in any respect necessary to satisfy the requirements of, or to take advantage of any features of, the revised
exemption or its replacement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify">EFFECT OF CHANGES IN CAPITALIZATION</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">15.1.</TD>
    <TD STYLE="text-align: justify">
Adjustments for Changes in Capital Structure</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to any required action by the Stockholders,
in the event of any change in the Common Stock effected without receipt of consideration by the Company, whether through merger, consolidation,
reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off,
spin-off, combination of shares, exchange of shares or similar change in the capital structure of the Company, or in the event of payment
of a dividend or distribution to the Stockholders in a form other than Shares (excepting normal cash dividends) that has a material effect
on the Fair Market Value, appropriate and proportionate adjustments shall be made in the number and class of shares subject to the Plan
and to any outstanding Awards, and in the Option Price, SAR Exercise Price or Purchase Price per Share of any outstanding Awards in order
to prevent dilution or enlargement of Participants&rsquo; rights under the Plan. For purposes of the foregoing, conversion of any convertible
securities of the Company shall not be treated as &ldquo;effected without receipt of consideration by the Company.&rdquo; If a majority
of the Shares which are of the same class as the Shares that are subject to outstanding Awards are exchanged for, converted into, or otherwise
become (whether or not pursuant to a Change in Control) shares of another corporation (the &ldquo;<B>New Shares</B>&rdquo;), the Board
may unilaterally amend the outstanding Awards to provide that such Awards are for New Shares. In the event of any such amendment, the
number of Shares subject to, and the Option Price, SAR Exercise Price or Purchase Price per Share of, the outstanding Awards shall be
adjusted in a fair and equitable manner. Any fractional share resulting from an adjustment pursuant to this <B>Section 15.1 </B>shall
be rounded down to the nearest whole number and the Option Price, SAR Exercise Price or Purchase Price per share shall be rounded up to
the nearest whole cent. In no event may the exercise price of any Award be decreased to an amount less than the par value, if any, of
the stock subject to the Award. The Board may also make such adjustments in the terms of any Award to reflect, or related to, such changes
in the capital structure of the Company or distributions as it deems appropriate. Adjustments determined by the Board pursuant to this
<B>Section 15.1</B> shall be made in accordance with Section 409A to the extent applicable.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">15.2.</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">

Change in Control</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">15.2.1.</TD>
    <TD STYLE="text-align: justify">
Consequences of a Change in Control</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Subject to the requirements and limitations of Section
409A if applicable, the Board may provide for any one or more of the following in connection with a Change in Control, which such actions
need not be the same for all Participants:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B>Accelerated Vesting</B>. The Board may provide in any Award Agreement, or in the event of a Change in Control may take such actions
as it deems appropriate to provide, for the acceleration of the exercisability, vesting or settlement in connection with such Change in
Control of each or any outstanding Award or portion thereof and Shares acquired pursuant thereto upon such terms, including a Participant&rsquo;s
Separation from Service prior to, upon, or following such Change in Control, to such extent as determined by the Board.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B>Assumption, Continuation or Substitution</B>. In the event of a Change in Control, the surviving, continuing, successor or purchasing
corporation or other business entity or parent thereof, as the case may be (the &ldquo;<B>Acquiror</B>&rdquo;), may, without the consent
of any Participant, either assume or continue the Company&rsquo;s rights and obligations under each or any Award or portion thereof outstanding
immediately prior to the Change in Control or substitute for each or any such outstanding Award or portion thereof a substantially equivalent
award with respect to the Acquiror&rsquo;s stock, as applicable. For purposes of this <B>Section 15.2.1</B>, an Award denominated in Shares
shall be deemed assumed if, following the Change in Control, the Award confers the right to receive, subject to the terms of the Plan
and the applicable Award Agreement, for each Share subject to the Award immediately prior to the Change in Control, the consideration
(whether stock, cash, other securities or property or a combination thereof) to which a Stockholder on the effective date of the Change
in Control was entitled; <I>provided, however</I>, that if such consideration is not solely common stock of the Acquiror, the Board may,
with the consent of the Acquiror, provide for the consideration to be received upon the exercise or settlement of the Award, for each
Share subject to the Award, to consist solely of common stock of the Acquiror equal in Fair Market Value to the per Share consideration
received by Stockholders pursuant to the Change in Control. If any portion of such consideration may be received by Stockholders pursuant
to the Change in Control on a contingent or delayed basis, the Board may determine such Fair Market Value as of the time of the Change
in Control on the basis of the Board&rsquo;s estimate of the present value of the probable future payment of such consideration. Any Award
or portion thereof which is neither assumed or continued by the Acquiror in connection with the Change in Control nor exercised or settled
as of the time of consummation of the Change in Control shall terminate and cease to be outstanding effective as of the time of consummation
of the Change in Control.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B>Cash-Out of Awards.</B> The Board may, without the consent of any Participant, determine that, upon the occurrence of a Change in Control,
each or any Award or a portion thereof outstanding immediately prior to the Change in Control and not previously exercised or settled
shall be canceled in exchange for a payment with respect to each vested Share (and each unvested Share, if so determined by the Board)
subject to such canceled Award in (i) cash, (ii) stock of the Company or of a corporation or other business entity a party to the Change
in Control or (iii) other property which, in any such case, shall be in an amount having a Fair Market Value equal to the Fair Market
Value of the consideration to be paid per Share in the Change in Control, reduced by the exercise or purchase price per Share, if any,
under such Award. If any portion of such consideration may be received by Stockholders pursuant to the Change in Control on a contingent
or delayed basis, the Board may determine such Fair Market Value as of the time of the Change in Control on the basis of the Board&rsquo;s
estimate of the present value of the probable future payment of such consideration. In the event such determination is made by the Board,
the amount of such payment (reduced by applicable withholding taxes, if any) shall be paid to Participants in respect of the vested portions
of their canceled Awards as soon as practicable following the date of the Change in Control and in respect of the unvested portions of
their canceled Awards in accordance with the vesting schedules applicable to such Awards. For avoidance of doubt, if the amount determined
pursuant to this <B>Section 15.2.1(c) </B>for an Option or SAR is zero or less, the affected Option or SAR may be cancelled without any
payment therefore.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">15.2.2.</TD>
    <TD STYLE="text-align: justify">
Change in Control Defined</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Unless otherwise provided in the applicable Award Agreement,
a &ldquo;<B>Change in Control</B>&rdquo; means the consummation of any of the following events:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the acquisition, other than from the Company, by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3) or Section&nbsp;14(d)(2)
of the Exchange Act), other than the Company or any subsidiary, affiliate (within the meaning of Rule 144 promulgated under the Securities
Act) or employee benefit plan of the Company, of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange
Act) of more than 50% of the combined voting power of the then outstanding voting securities of the Company entitled to vote generally
in the election of directors (the &ldquo;<B>Voting Securities</B>&rdquo;); or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a reorganization, merger, consolidation or recapitalization of the Company (a &ldquo;<B>Business Combination</B>&rdquo;), other than a
Business Combination in which more than 50% of the combined voting power of the outstanding voting securities of the surviving or resulting
entity immediately following the Business Combination is held by the persons who, immediately prior to the Business Combination, were
the holders of the Voting Securities; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a complete liquidation or dissolution of the Company, or a sale of all or substantially all of the assets of the Company; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
during any period of 12 consecutive months, the Incumbent Directors cease to constitute a majority of the Board; &ldquo;<B>Incumbent Directors</B>&rdquo;
means individuals who were members of the Board at the beginning of such period or individuals whose election or nomination for election
to the Board by the Stockholders was approved by a vote of at least a majority of the then Incumbent Directors (but excluding any individual
whose initial election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding the foregoing, if it is determined
that an Award is subject to the requirements of Section&nbsp;409A and payable upon a Change in Control, the Company will not be deemed
to have undergone a Change in Control for purposes of the Plan unless the Company is deemed to have undergone a &ldquo;change in control
event&rdquo; pursuant to the definition of such term in Section&nbsp;409A.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">15.3.</TD>
    <TD STYLE="text-align: justify">Adjustments</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify"></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Adjustments under this <B>Section&nbsp;15</B> related
to Shares or other securities of the Company shall be made by the Board. No fractional Shares or other securities shall be issued pursuant
to any such adjustment, and any fractions resulting from any such adjustment shall be eliminated in each case by rounding downward to
the nearest whole Share.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify">No Limitations on Company</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The making of Awards shall not affect or limit in any
way the right or power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structure
or to merge, consolidate, dissolve or liquidate, or to sell or transfer all or any part of its business or assets.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify">TERMS APPLICABLE GENERALLY TO AWARDS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.1.</TD>
    <TD STYLE="text-align: justify">Disclaimer of Rights</TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">No provision in the Plan or in any Award Agreement
shall be construed to confer upon any individual the right to remain in the employ or service of the Company or any Affiliate, or to interfere
in any way with any contractual or other right or authority of the Company or any Affiliate either to increase or decrease the compensation
or other payments to any individual at any time, or to terminate any employment or other relationship between any individual and the Company
or any Affiliate. In addition, notwithstanding anything contained in the Plan to the contrary, unless otherwise provided in the applicable
Award Agreement, no Award shall be affected by any change of duties or position of the Participant, so long as such Participant continues
to be a Service Provider. The obligation of the Company to pay any benefits pursuant to the Plan shall be interpreted as a contractual
obligation to pay only those amounts described herein, in the manner and under the conditions prescribed herein. The Plan shall in no
way be interpreted to require the Company to transfer any amounts to a third party trustee or otherwise hold any amounts in trust or escrow
for payment to any Participant or beneficiary under the terms of the Plan.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.2.</TD>
    <TD STYLE="text-align: justify">Nonexclusivity of the Plan</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Neither the adoption of the Plan nor the submission
of the Plan to the Stockholders for approval shall be construed as creating any limitations upon the right or authority of the Board or
its delegate to adopt such other compensation arrangements as the Board or its delegate determines desirable.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.3.</TD>
    <TD STYLE="text-align: justify">Withholding Taxes</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Company or an Affiliate, as the case may be, shall
have the right to deduct from payments of any kind otherwise due to a Participant any federal, state or local taxes of any kind required
by law to be withheld (i)&nbsp;with respect to the vesting of or other lapse of restrictions applicable to an Award, (ii)&nbsp;upon the
issuance of any Shares upon the exercise of an Option or SAR or (iii)&nbsp;otherwise due in connection with an Award. At the time of such
vesting, lapse or exercise, the Participant shall pay to the Company or the Affiliate, as the case may be, any amount that the Company
or the Affiliate may reasonably determine to be necessary to satisfy such withholding obligation. In addition, the Board may provide one
or more Participants with the right to direct the Company to withhold, from the Shares otherwise issuable upon the exercise of an Option
or Stock Appreciation Right or upon the issuance of fully-vested Shares (whether pursuant to Restricted Stock, RSUs, Other Share-based
Awards, or otherwise), a portion of those Shares with an aggregate Fair Market Value equal to the percentage of the applicable withholding
taxes (not to exceed one hundred percent (100%)) designated by the Participant;&nbsp;<B><I>provided, however</I></B>, that the amount
of any Shares so withheld shall not exceed the amount necessary to satisfy the Company&rsquo;s required tax withholding obligations using
not more than the applicable maximum statutory withholding rates (or such other rates as required to avoid adverse accounting treatment
as determined by the Board). The Fair Market Value of the Shares used to satisfy such withholding obligation shall be determined by the
Company or the Affiliate as of the date that the amount of tax to be withheld is to be determined. A Participant who has made an election
pursuant to this <B>Section&nbsp;17.3</B> may satisfy his or her withholding obligation only with Shares that are not subject to any repurchase,
forfeiture, unfulfilled vesting or other similar requirements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.4.</TD>
    <TD STYLE="text-align: justify">Other Provisions; Legends</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify"></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each Award Agreement may contain such other terms not
inconsistent with the Plan as may be determined by the Board. Any stock certificates for any Shares issued under the Plan shall be subject
to such stop-transfer orders and other restrictions as the Company in its sole discretion may deem advisable under the rules, regulations
and other requirements of the SEC, any securities exchange on which the Common Stock may then be listed and any applicable federal or
state securities law, and the Company in its sole discretion may cause a legend or legends to be placed on such certificates to make appropriate
reference to such restrictions.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.5.</TD>
    <TD STYLE="text-align: justify">Severability</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If any provision of the Plan or any Award Agreement
shall be determined to be illegal or unenforceable by any court of law in any jurisdiction, the remaining provisions hereof and thereof
shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.6.</TD>
    <TD STYLE="text-align: justify">Governing Law</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Plan shall be governed by and construed in accordance
with the internal laws of the Commonwealth of Massachusetts without regard to the principles of conflicts of law thereof or principles
of conflicts of laws of any other jurisdiction that could cause the application of the laws of any jurisdiction other than the Commonwealth
of Massachusetts. For purposes of resolving any dispute that arises directly or indirectly in connection with the Plan, each Participant,
by virtue of receiving an Award, shall be deemed to have submitted to and consented to the exclusive jurisdiction of the Commonwealth
of Massachusetts and to have agreed that any related litigation shall be conducted solely in the courts of Middlesex County, Massachusetts
or the United States District Court for the District of Massachusetts, where the Plan is made and to be performed, and no other courts.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.7.</TD>
    <TD STYLE="text-align: justify">Section&nbsp;409A</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Plan is intended to comply with Section&nbsp;409A,
and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance therewith. Any payments
described in the Plan that are due within the &ldquo;short-term deferral period&rdquo; as defined in Section&nbsp;409A shall not be treated
as deferred compensation unless applicable laws require otherwise. Notwithstanding anything to the contrary in the Plan, to the extent
required to avoid accelerated taxation and tax penalties under Section&nbsp;409A, amounts that would otherwise be payable and benefits
that would otherwise be provided pursuant to the Plan during the six-month period immediately following the Participant&rsquo;s Separation
from Service shall instead be paid on the first payroll date after the six-month anniversary of the Participant&rsquo;s Separation from
Service (or the Participant&rsquo;s death, if earlier). Notwithstanding the foregoing, neither the Company nor the Committee shall have
any obligation to take any action to prevent the assessment of any excise tax or penalty on any Participant under Section&nbsp;409A and
neither the Company nor the Board shall have any liability to any Participant for such tax or penalty.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.8.</TD>
    <TD STYLE="text-align: justify">Separation from Service</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board shall determine the effect of a Separation
from Service upon Awards, and such effect shall be set forth in the applicable Award Agreement. Without limiting the foregoing, the Board
may provide in the Award Agreements at the time of grant, or any time thereafter with the consent of the Participant, the actions that
will be taken upon the occurrence of a Separation from Service, including accelerated vesting or termination, depending upon the circumstances
surrounding the Separation from Service.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">17.9.</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Transferability of Awards</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.9.1.</TD>
    <TD STYLE="text-align: justify">Transfers in General</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Except as provided in <B>Section&nbsp;17.9.2</B>, no
Award shall be assignable or transferable by the Participant to whom it is granted, other than by will or the laws of descent and distribution,
and, during the lifetime of the Participant, only the Participant personally (or the Participant&rsquo;s personal representative) may
exercise rights under the Plan.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.9.2.</TD>
    <TD STYLE="text-align: justify">Family Transfers</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">If authorized in the applicable Award Agreement, a Participant
may transfer, not for value, all or part of an Award (other than Incentive Stock Options) to any Family Member. For the purpose of this
<B>Section&nbsp;17.9.2</B>, a &ldquo;not for value&rdquo; transfer is a transfer which is (i)&nbsp;a gift, (ii)&nbsp;a transfer under
a domestic relations order in settlement of marital property rights or (iii)&nbsp;a transfer to an entity in which more than 50% of the
voting interests are owned by Family Members (or the Participant) in exchange for an interest in that entity. Following a transfer under
this <B>Section&nbsp;17.9.2</B>, any such Award shall continue to be subject to the same terms as were applicable immediately prior to
transfer. Subsequent transfers of transferred Awards are prohibited except to Family Members of the original Participant in accordance
with this <B>Section&nbsp;17.9.2</B> or by will or the laws of descent and distribution.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.10.</TD>
    <TD STYLE="text-align: justify">Dividends and Dividend Equivalent Rights</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If specified in the Award Agreement, the recipient
of an Award may be entitled to receive, currently or on a deferred basis, dividends or dividend equivalents with respect to the Common
Stock or other securities covered by an Award; <I>provided</I>, <I>however</I>, that no dividends or dividend equivalents may be paid
or granted with respect to an Option or SAR or the Shares subject thereto until such Award has been exercised. The terms of a dividend
equivalent right may be set forth in the Award Agreement. Dividend equivalents credited to a Participant may be paid currently or may
be deemed to be reinvested in additional Shares or other securities of the Company at a price per unit equal to the Fair Market Value
on the date that such dividend was paid to Stockholders. Notwithstanding the foregoing, in no event will dividends or dividend equivalents
on any Award that is subject to vesting conditions (including the achievement of performance criteria) be payable before the Award has
become vested.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.11.</TD>
    <TD STYLE="text-align: justify">Data Protection</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">A Participant&rsquo;s acceptance of an Award shall
be deemed to constitute the Participant&rsquo;s acknowledgement of and consent to the collection and processing of personal data relating
to the Participant so that the Company and the Affiliates can fulfill their obligations and exercise their rights under the Plan and generally
administer and manage the Plan. This data shall include data about participation in the Plan and Shares offered or received, purchased
or sold under the Plan and other appropriate financial and other data (such as the date on which the Awards were granted) about the Participant
and the Participant&rsquo;s participation in the Plan.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in">17.12.</TD>
    <TD STYLE="text-align: justify">Plan Construction</TD></TR>
  </TABLE>

<P STYLE="margin: 0pt; font-size: 10pt; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">In the Plan, unless otherwise stated, the following
uses apply: (i)&nbsp;references to a statute or law refer to the statute or law and any amendments and any successor statutes or laws,
and to all valid and binding governmental regulations, court decisions and other regulatory and judicial authority issued or rendered
thereunder, as amended, or their successors, as in effect at the relevant time; (ii)&nbsp;in computing periods from a specified date to
a later specified date, the words &ldquo;from&rdquo; and &ldquo;commencing on&rdquo; (and the like) mean &ldquo;from and including,&rdquo;
and the words &ldquo;to,&rdquo; &ldquo;until&rdquo; and &ldquo;ending on&rdquo; (and the like) mean &ldquo;to and including&rdquo;; (iii)&nbsp;indications
of time of day shall be based upon the time applicable to the location of the principal headquarters of the Company; (iv)&nbsp;the words
&ldquo;include,&rdquo; &ldquo;includes&rdquo; and &ldquo;including&rdquo; (and the like) mean &ldquo;include, without limitation,&rdquo;
&ldquo;includes, without limitation&rdquo; and &ldquo;including, without limitation&rdquo; (and the like), respectively; (v)&nbsp;all
references to articles and sections are to articles and sections in the Plan; (vi)&nbsp;all words used shall be construed to be of such
gender or number as the circumstances and context require; (vii)&nbsp;the captions and headings of articles and sections have been inserted
solely for convenience of reference and shall not be considered a part of the Plan, nor shall any of them affect the meaning or interpretation
of the Plan or any of its provisions; (viii)&nbsp;any reference to an agreement, plan, policy, form, document or set of documents, and
the rights and obligations of the parties under any such agreement, plan, policy, form, document or set of documents, shall mean such
agreement, plan, policy, form, document or set of documents as amended from time to time, and any and all modifications, extensions, renewals,
substitutions or replacements thereof; and (ix)&nbsp;all accounting terms not specifically defined shall be construed in accordance with
GAAP.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 75%">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 30%; font-size: 10pt; font-weight: bold; text-align: left; text-indent: 0in; padding-left: 0pt">Adopted by the Board:</TD>
    <TD STYLE="width: 70%; font-size: 10pt; font-weight: bold">March 31, 2017</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: 0in; padding-left: 0pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: 0in; padding-left: 0pt">Approved by the Stockholders:</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold">June 13, 2017</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: 0in; padding-left: 0pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; font-weight: bold; text-align: left; text-indent: 0in; padding-left: 0pt">Amended by the Stockholders:</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold">June 18, 2019; June 16, 2020; June 16, 2021; June 8, 2022; June 14, 2023; June 20, 2025</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: 0in; padding-left: 0pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: 0in; padding-left: 0pt">Scheduled Termination Date:</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold">June 13, 2027</TD></TR>
  </TABLE>


<P STYLE="margin: 0pt 0 0pt 1in; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 1in; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 1in; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 1in; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">20</P>

<P STYLE="margin: 0pt; font-size: 10pt; text-indent: 0in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0pt; font-size: 10pt; text-indent: 0in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>anik-20250620.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qkpo7xRiXgen8uJbHxcOaqC+bP9wpB0OZkxsGx8HWkq3yYqRm9PvSJbEgK2IQUG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ANIK="http://globenewswire.com/20250620" elementFormDefault="qualified" targetNamespace="http://globenewswire.com/20250620">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://globenewswire.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="anik-20250620_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="anik-20250620_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>anik-20250620_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>anik-20250620_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://globenewswire.com/role/Cover" xlink:href="anik-20250620.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://globenewswire.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 20,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-21326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Anika Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000898437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3145961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">32 Wiggins Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bedford<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">457-9000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ANIK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="f8k_062425.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globenewswire.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>anik-20250620.xsd</File>
    <File>anik-20250620_lab.xml</File>
    <File>anik-20250620_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="f8k_062425.htm">f8k_062425.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "f8k_062425.htm": {
   "nsprefix": "ANIK",
   "nsuri": "http://globenewswire.com/20250620",
   "dts": {
    "schema": {
     "local": [
      "anik-20250620.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "anik-20250620_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "anik-20250620_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "f8k_062425.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://globenewswire.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f8k_062425.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f8k_062425.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001171843-25-004062-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-25-004062-xbrl.zip
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M;0]G@THOR+2M6H$YR,+#I>6M#Q85H-8S*L0G)OG"ZE;<"?Z2L A>,D-R+\
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MT4)AJ!3;@A;;,\PS,-A1!HD5UC1US1ISEAT:-KBE#82KI#A,]]OZ/=ZF(*/
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M,:(#BU9)740:Q;.*:,"]RU4INW9UG!=([D^OTSS-PJ^DZVWXZX *96'EZ)P
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MIR#.FVC,.FWHW<;J5Q->%VER)[-*HH *9+D4V/":Z%[\9990H16:#L6T@A&
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M0:JTH6ASCBR!'^4374E)TM@L.K2:Q" F_A !X#7LS &MV+SPK4S""!GSG9[
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M[=2KUEVJJBH"TBW,C2*+A&V$YE/Z$SX%TZXD+Z@K"XIZLZ'(O55"A%?+$2+
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M .YS8HIFTQ$[YKP[+\M=EU\)N2 $.15RK+],&&3O88:(D(I"(Q\P:TL$7$;
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MYTC2?C%9TE3))3!<;-XLV@B[(Z)#1AB,Z*"L-K.EIV/CR[ECX?ER%>%Y@A:
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M?U U4/Z*(5],2"YZ, EQI3&;S8F#;$'"C@[]:U[-HT8[C-?*5SQ-'1C"D$/
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M-D&\]MSHI'S_]N.[?Q*T]O?3/][_\O\!4$L#!!0    ( "N(V%K!@>[Z(Q@
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M+1)ZNT;@K4_@TV'E\\M.>_0N5&X92 U0 '_K$V9J\,\],^C=[8@:#ML!4BD
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MZ:'FST\:7=L,I1^W3O B%VHJNSL:;7(7>KI$U:*E=.J5EYC'4%IE,V[/G$\
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M6O-L([<$ZWE-W]<1J<W\RM<)5EF+F"2)U%F+?&;CD UBYFUN7AO<9O0^/63
M?4!PRA$^_(#!U.ON6=?G[#3:YM6'*95B*!6N__8M#KQ!U+V5DME:C-.KF]P+
M;;ML0@H92<FLW$S\-ZPU&;A>[LQF"1#3IFZ#Y%JV@PN@ 2-3L"-=7IBRG6/2
M,IB_QV'5])C4IU-+-UT>.L*3]7ZHD9CIX-[Y!:G;-JX";.W$-<]$'.'="_5[
MZRJ]MCPPM(P(-^Q.)(H$MJX[,?7AS,%O<,_! R/7!C5W3\WOBW'7!.;;ND$4
M6>Q#37&DAQ:H)J1 \R<IA1.*CT[Q40J?;:+,;YIH^&J8:M84-2NH/)'9?V
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M97IA]>7QYYMKI]BM7/ZG>5D^+_?OG7>"(]FAI2WPY]B=&+7_ 5!+ 0(4 Q0
M   ( "N(V%HM(2VW+P,  /$+   1              "  0    !A;FEK+3(P
M,C4P-C(P+GAS9%!+ 0(4 Q0    ( "N(V%KS6YM8_0H  '^&   5
M      "  5X#  !A;FEK+3(P,C4P-C(P7VQA8BYX;6Q02P$"% ,4    "  K
MB-A:S5]2HEH'  #>5P  %0              @ &.#@  86YI:RTR,#(U,#8R
M,%]P<F4N>&UL4$L! A0#%     @ *XC86CR/%:>^:   2)X"  L
M     ( !&Q8  &5X:%\Q,#$N:'1M4$L! A0#%     @ *XC86L&![OHC&
MVX4   X              ( ! G\  &8X:U\P-C(T,C4N:'1M4$L%!@     %
-  4 .@$  %&7      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>f8k_062425_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="anik-20250620.xsd" xlink:type="simple"/>
    <context id="AsOf2025-06-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
        </entity>
        <period>
            <startDate>2025-06-20</startDate>
            <endDate>2025-06-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-06-20" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-20" id="Fact000004">0000898437</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-06-20" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-06-20" id="Fact000010">2025-06-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-20" id="Fact000011">Anika Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-06-20" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-06-20" id="Fact000013">000-21326</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-06-20" id="Fact000014">04-3145961</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-06-20" id="Fact000015">32 Wiggins Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-06-20" id="Fact000016">Bedford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-06-20" id="Fact000017">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-06-20" id="Fact000018">01730</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-06-20" id="Fact000019">(781)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-06-20" id="Fact000020">457-9000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-06-20" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-06-20" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-06-20" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-06-20" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-06-20" id="Fact000026">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-06-20" id="Fact000027">ANIK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-06-20" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-06-20" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
